RTsafe was founded in 2014 by medical physics professors with considerable experience in the field of radiation oncology, aiming to address the issue of quality assurance in radiotherapy.
RTsafe expanded rapidly and established collaborations with renowned hospitals and academic institutions thanks to the exceptional teamwork of its experienced scientists and software developers. Our customers’ confidence in our products and services make us feel proud and inspire us to keep thinking forward and consistently improve the quality of our solutions.
RTsafe offers dosimetry services which incorporate phantoms built from real patient anatomical data by combining proven expertise in medical physics with highly accurate 3D printing technology.
RTsafe’s vision is to make Stereotactic Radiosurgery / Radiotherapy (SRS/SRT) more efficient and accessible with patient-specific quality control procedures that enhance patient safety and empower confidence in using such challenging and advanced radiotherapy techniques. RTsafe’s complete armamentarium of solutions (personalized and generic, using 1, 2 and 3D dosimetry services) is currently offered to the whole radiotherapy community by a growing network of distributors worldwide. The patent concerns Personalized (i.e. patient-specific) Radiotherapy Treatment Verification and Quality Assurance.